arrow
Back
P

Patrick A. Baeuerle

University of Munich

122H-index
450Paper Count
6.4WCitation Count
Published Papers 113
Publication Date
CLN-619, a MICA/B monoclonal antibody that promotes innate immune cell-mediated antitumor activity
err2025-04-23
err0
errOAAI
errWhalen, Kerry A.; Henry, Catherine C.; Mehta, Naveen K.; Rakhra, Kavya; Yalcin, Safak; Meetze, Kristan; Gibson, Neil W.; Baeuerle, Patrick A.; Michaelson, Jennifer S.
errShare
errSave
Intratumoral injection and retention hold promise to improve cytokine therapies for cancer
err2024-08-26
err0
errOAAI
errSauer, Karsten; Rakhra, Kavya; Wu, Kaida; Mehta, Naveen K.; Michaelson, Jennifer S.; Baeuerle, Patrick A.
errShare
errSave
errShare
errSave
CLN-619, a clinical stage MICA/B-specific hIgG1 monoclonal antibody, engages multiple immune effector cells to promote anti-tumor activity
err2024-03-22
err0
PREAI
errWhalen, Kerry A.; Henry, Catherine C.; Rakhra, Kavya; Meetze, Kristan; Michaelson, Jennifer S.; Baeuerle, Patrick A.
errShare
errSave
Engaging natural killer cells for cancer therapy via NKG2D, CD16A and other receptors
errMABS
IF7.3
err2023-05-10
err14
errOAAI
errWhalen, Kerry A.; Rakhra, Kavya; Mehta, Naveen K.; Steinle, Alexander; Michaelson, Jennifer S.; Baeuerle, Patrick A.
errShare
errSave
CLN-617 is a first-in-class fusion protein that retains IL-2 and IL-12 in the injected tumor and potently triggers systemic anti-tumor immunity
err2023-04-04
err0
PREAI
errMehta, Naveen K.; Rakhra, Kavya; Meetze, Kristan; Wittrup, K. Dane; Michaelson, Jennifer S.; Baeuerle, Patrick A.
errShare
errSave
Mesothelin-targeting T cells bearing a novel T cell receptor fusion construct (TRuC) exhibit potent antitumor efficacy against solid tumors
err2023-02-24
err13
errOAAI
errDing, Jian; Guyette, Sarah; Schrand, Brett; Geirut, Jessica; Horton, Holly; Guo, Guangwu; Delgoffe, Greg; Menk, Ashley; Baeuerle, Patrick A.; Hofmeister, Robert; Tighe, Robert
errShare
errSave
TriTACs, a Novel Class of T-Cell-Engaging Protein Constructs Designed for the Treatment of Solid Tumors
err2021-01-05
err30
errOAAI
errAustin, Richard J.; Lemon, Bryan D.; Aaron, Wade H.; Barath, Manasi; Culp, Patricia A.; DuBridge, Robert B.; Evnin, Luke B.; Jones, Adrie; Panchal, Anand; Patnaik, Purbasa; Ramakrishnan, Vanitha; Rocha, Sony S.; Seto, Pui; Sexton, Kenneth; Strobel, Kathryn L.; Wall, Russell; Yu, Stephen; Yu, Timothy Z.; Law, Che-Leung; Baeuerle, Patrick A.; Wesche, Holger
errShare
errSave
Expression and function of epithelial cell adhesion molecule EpCAM: where are we after 40 years?
err2020-06-07
err206
errOAAI
errGires, Olivier; Pan, Min; Schinke, Henrik; Canis, Martin; Baeuerle, Patrick A.
errShare
errSave
Preclinical evaluation of TC-110: CD19-specific T cell receptor (TCR) fusion construct (TRuC™) T cell for the treatment of hematologic malignancies
err2019-07-01
err0
PREAI
errHorton, Holly; Ding, Jian; Shah, Seema; Gierut, Jessica; Thorausch, Niko; Morath, Anna; Shamel, Wolfgang; Maus, Marcela; Baeuerle, Patrick; Hofmeister, Robert; Getts, Daniel R.
errShare
errSave
Synthetic TRuC receptors engaging the complete T cell receptor for potent anti-tumor response
err2019-05-07
err142
errOAAI
errBaeuerle, Patrick A.; Ding, Jian; Patel, Ekta; Thorausch, Niko; Horton, Holly; Gierut, Jessica; Scarfo, Irene; Choudhary, Rashmi; Kiner, Olga; Krishnamurthy, Janani; Le, Bonnie; Morath, Anna; Baldeyiano, G. Christian; Quinn, Justin; Tayares, Patrick; Wei, Qi; Weiler, Solly; Maus, Marcela, V; Getts, Daniel; Schamel, Wolfgang W.; Hofmeister, Robert
errShare
errSave
Antiviral Activity of HIV gp120-Targeting Bispecific T Cell Engager Antibody Constructs
err2018-07-15
err34
errOAAI
errBrozy, Johannes; Schlaepfer, Erika; Mueller, Christina K. S.; Rochat, Mary-Aude; Rampini, Silvana K.; Myburgh, Renier; Raum, Tobias; Kufer, Peter; Baeuerle, Patrick A.; Muenz, Markus; Speck, Roberto F.
errShare
errSave
HPN536, a T cell-engaging, mesothelin/CD3-specific TriTAC for the treatment of solid tumors
err2018-07-01
err5
PREAI
errAustin, Richard; Aaron, Wade; Baeuerle, Patrick; Barath, Manasi; Jones, Adrie; Jones, Susan D.; Law, Che-Leung; Kwant, Kathryn; Lemon, Bryan; Muchnik, Anna; Sexton, Kenneth; Tatalick, Laurie; Wesche, Holger; Yu, Timothy
errShare
errSave
Preclinical evaluation of mesothelin-specific T cell receptor (TCR) fusion constructs (TRuC™s) utilizing the signaling power of the complete TCR complex: A new opportunity for solid tumor therapy
err2018-07-01
err1
PREAI
errDing, Jian; Patel, Ekta; Tavares, Patrick; Quinn, Justin; Choudhary, Rashmi; Le, Bonnie; Kiner, Olga; Weiler, Solly; Getts, Daniel R.; Baeuerle, Patrick; Hofmeister, Robert
errShare
errSave
HPN424, a half-life extended, PSMA/CD3-specific TriTAC for the treatment of metastatic prostate cancer
err2018-07-01
err5
PREAI
errLemon, Bryan; Aaron, Wade; Austin, Richard; Baeuerle, Patrick; Barath, Manasi; Jones, Adrie; Jones, Susan D.; Kwant, Kathryn; Law, Che-Leung; Muchnik, Anna; Sexton, Kenneth; Tatalick, Laurie; Wesche, Holger; Yu, Timothy
errShare
errSave
Characterization of a novel class of engineered (TCR) fusion constructs (TRuC™s) aimed to treat solid tumors
err2018-07-01
err1
PREAI
errPatel, Ekta; Ding, Jian; Thorausch, Nikolaus; Krishnamurthy, Janani; Choudhary, Rashmi; Weiler, Solly; Le, Bonnie; Tavares, Patrick; Zieba, Adam; Quinn, Justin; Wang, Yan; Schamel, Wolfgang; Scarfo, Irene; Maus, Marcela; Baeuerle, Patrick; Getts, Dainel; Hofmeister, Robert
errShare
errSave
TriTACs are novel T cell-engaging therapeutic proteins optimized for the treatment of solid tumors and for long serum half-life
err2018-07-01
err3
PREAI
errWesche, Holger; Aaron, Wade; Austin, Richard J.; Baeuerle, Patrick A.; Jones, Adrie; Lemon, Bryan; Sexton, Kenneth
errShare
errSave
Changes in clinical laboratory parameters and pharmacodynamic markers in response to blinatumomab treatment of patients with relapsed/refractory ALL
err2017-05-18
err61
errOAAI
errNaegele, Virginie; Kratzer, Andrea; Zugmaier, Gerhard; Holland, Chris; Hijazi, Youssef; Topp, Max S.; Goekbuget, Nicola; Baeuerle, Patrick A.; Kufer, Peter; Wolf, Andreas; Klinger, Matthias
errShare
errSave
Redirecting T cells to eradicate B-cell acute lymphoblastic leukemia: bispecific T-cell engagers and chimeric antigen receptors
errLEUKEMIA
IF13.4
err2016-12-28
err55
PREAI
errAldoss, I.; Bargou, R. C.; Nagorsen, D.; Friberg, G. R.; Baeuerle, P. A.; Forman, S. J.
errShare
errSave